KYOWA HAKKO BIO CO. LTD. (Kyowa Hakko Bio), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), completed a production facility for human milk oligosaccharides (HMOs) on November 18, 2022 at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety...
Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this prestigious NutraIngredients Award given to its flagship product Cognizin® Citicoline...
December 5 - 8, 2022
Paris, France
Booth #7.2G101
February 6 - 8, 2023
Barcelona, Spain
Gold Sponsor
The Kyowa Quality (KQ) brand consists of an extensive line of ultra-pure amino acids and related compounds supplied by KYOWA HAKKO BIO CO., LTD. (KYOWA), a global leader with over 60 years of manufacturing expertise and a reputation for rigorous quality assurance.
